Plasma Cell::Multiple Myeloma
Top PDF Plasma Cell::Multiple Myeloma:
Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
... age, myeloma subtype, disease stage based on ISS (3), haemoglobin, serum beta-2 microglobulin (B2M), serum calcium, serum creati- nine, serum albumin, serum immunoglobulin, immunoparesis of non-monoclonal immuno- ...
17
Capacidad insuficiente de la cuantificacin de cadenas ligeras totales en el diagnstico y seguimiento de pacientes con mieloma mltiple
... in plasma cell disorders has been serum protein electro- phoresis (SPE) with immunofixation electrophoresis (IFx); serum total and free light chain quantifications have also been ...with multiple ...
5
Diagnstico y tratamiento del mieloma mltiple en el 2010
... Multiple myeloma is a plasma cell neoplasm that accounts for slightly more than 10% of hematologic ...marrow plasma cells, serum and/or urinary M protein and evidence of end organ ...
10
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).
... overall incidence rates range from a high of 13.1/100,000 per year for black males to 2.9/100,000 per year for white females (8,11). MM is common in the elderly, with incidence rates increasing with age, it occurs rarely ...
14
Trasplante doble en una paciente con mieloma mltiple: mdula sea y rin
... Multiple myeloma (MM) is described as a clonal plasma B-cell hematolo- gical ...of plasma cells produces monoclonal heavy or light chain ...later multiple myeloma was ...
5
Mieloma no secretor Una variante poco frecuente
... Non-secretory myeloma (NSMM) is a rare pre- sentation of multiple myeloma, which occurs in 1% of ...nant plasma cells are incapable to synthesize immunoglobulins or non-secretor when the ...
5
Tolerogenic dendritic cells as a therapy for treating lupus
... Based on the general mechanisms underlying autoimmune diseases, the most logical goal of any treatment would be to restore immune tolerance to self antigens without compromis- ing the ability of the immune system to ...
9
Hepatitis B reactivation in patients with multiple myeloma and isolated positive hepatitis B core antibody: a call for greater cognizance
... reactivation in a single center retrospective and pro- spective combined study. Retrospective chart review identified one patient with negative HBsAg and anti- HBc, but positive anti-HBs who developed HBV re- activation ...
5
Variations in the lipid profile of patients with chronic renal failure treated with pyridoxine
... Lipids from plasma and erythrocyte membranes were extracted with chloroform-methanol (2:1 v/v). An aliquot from the organic phase was methylated and analyzed using a Hewlett-Packard Model 5840-A gas-liquid chro- ...
6
Thalidomide and Dexamethasone Induction Therapy Until Best Response in Recently Diagnosed Patients with Multiple Myeloma: Results From a Pilot Study
... of stimulating T-cell, interleukin-2 (IL-2), and interfer- on (IFN)-γ production. Lenalidomide has been shown to be anywhere from 50 to 2,000 times more potent than thalidomide in the stimulation of T-cell ...
9
Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response.
... Flow cytometry phenotype. Flow cytometry phenotyping and intracellular staining were carried out in cryopreserved cells after the 12 months of treatment and before classification as RP or NRP (Fig. 2) to preserved the ...
10
Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project
... with multiple myeloma ...EORTC-QLQ- Multiple Myeloma (MY20) and EORTC-QLQ-Breast Cancer (BR23), pain Visual Analogue Scale, Morisky-Green and ad hoc questions about patients’ ...
8
Un acercamiento actualizado a la Esclerosis Mltiple
... Multiple Sclerosis is a complex disease; some evi- dences relate environment infl uence over genetically susceptible persons as the factors involved in the be- ginning of MS. The infl ammatory response -mediated ...
6
Hundred joules plasma focus device as a potential pulsed source for in vitro cancer cell irradiation
... and cell death were assessed after irradiation. A mock condition (cell culture that was not irradiated but follow the same path as the irradiated cell culture) was used as con- ...
7
Dynamics of Adrenal Steroids Are Related to Variations in Th1 and Treg Populations during Mycobacterium tuberculosis Infection in HIV Positive Persons
... in plasma from patients and healthy donors ...DHEA plasma levels were significantly diminished in HIV-TB and IRIS patients compared to HD, HIV-LTB and HIV+ individuals ...
10
HLA risk haplotype: insulin deficiency in pediatric Type 1 diabetes
... The aim of this study was to search for differences in markers of β-cell function (assessed by plasma proin- sulin, insulin, C-peptide, HbA1c), β -cell antibodies (AB) (i.e. anti-glutamic acid ...
9
Trasplante de clulas hematopoyticas en mieloma mltiple
... Multiple myeloma (MM) is the second most common hematologic malignancy, affecting approximately 14,000 new patients per year in the United ...stem cell support can be applied safely in these patients ...
9
Analysis of availability and access of anti-myeloma drugs and impact on the management of multiple myeloma in Latin American countries.
... for multiple myeloma in the world and dif fi culties of access to new agents and real-world practice are important ...anti-multiple myeloma drugs such as health care systems, approval times, ...
8
Risk genes in head and neck cancer: a systematic review and meta-analysis of last 5 years
... Most of studies included in this paper are from the United States, but Europe, Asia and South America are also represented. Nonetheless, it is not possible to compare the prevalence of HNC among the countries, because ...
25
Escleredema de Buschke: un artculo de revisin
... Se explican clásicamente tres subtipos de escleredema: el tipo I, como enfermedad autolimitada de inicio agu- do (2 a 4 semanas) que se presenta luego de un episodio febril, secundario generalmente a una infección de ...
8